Providence Alaska awarded grant for pediatric cancer care
November 19, 2015
$50,000 grant from St. Baldrick’s Foundation provides funds for research, enrollment in clinical trials
Anchorage, AK — The St. Baldrick’s Foundation, a volunteer-powered charity dedicated to raising money for children’s cancer research and funding the most promising research initiatives, announced it has awarded an infrastructure grant for $50,000 to The Children’s Hospital at Providence, a hospital-within-a-hospital at Providence Alaska Medical Center.
These infrastructure grants provide resources to institutions enabling them to conduct more research and enroll more children in ongoing clinical trials.
The Children’s Hospital at Providence will use this grant to hire a part-time clinical research associate and pay for additional phase II studies, which provide detailed information about treatment effectiveness.
Providence Alaska Medical Center is one of 33 institutions across the United States to receive a grant. This series of St. Baldrick’s Infrastructure Grants, totaling $2 million, combined with the more than $21.2 million awarded in July, brings the St. Baldrick’s Foundation’s funding total to $23 million awarded in 2015.
“This grant is wonderful news for our patients, providing funds that will support our commitment to caring for Alaska’s children by ensuring high-quality care close to home,” said Kate Mohr, RN, executive director of The Children’s Hospital at Providence. “Pediatric cancer care continues to advance in Alaska. This funding will help our pediatric oncology team continue to provide comprehensive outpatient and inpatient care, dedicated to the unique needs of children and families undergoing this challenging disease.”
Infrastructure grants are awarded based on the need of the institution and its patients, anticipated results of the grant and local participation in St. Baldrick’s fundraising events and activities.
“The St. Baldrick’s Foundation is excited to fund this latest round of grants, which will give much needed support to multiple pediatric cancer treatment teams across the U.S.,” said Kathleen Ruddy, chief executive officer of St. Baldrick’s. “These grants will improve the capacity of the institutions to do more research, enroll more children in cutting-edge clinical trials, and complete studies that are in progress. These grants would not be possible without our dedicated volunteers and generous donors who believe that kids deserve better than the toxic medicines that are currently available which all too often harm developing bodies and create lifelong, life-threatening health problems.”